经济观察网ST四环于2026年1月27日披露2025年度业绩预告，预计净利润亏损3000万元至4000万元，扣 非净利润亏损3300万元至4600万元，扣除后营业收入为3.3亿元至3.5亿元。公司同时发布退市风险提示 公告，因2024年度审计报告显示净利润为负且营业收入低于3亿元，股票自2025年4月30日起被实施退市 风险警示。若2025年度报告触及《深圳证券交易所股票上市规则》第9.3.12条情形，股票可能被终止上 市。 股票近期走势 近7个交易日(2026年2月6日至2月12日)，ST四环股价呈现波动下行趋势。截至2月12日收盘价2.55元， 较2月6日收盘价2.61元累计下跌约2.3%，区间振幅达12.28%。成交方面，2月11日成交额达3036.97万 元，换手率1.15%，显示交投活跃；资金流向以主力净流出为主，如2月12日主力净流出426.07万元，而 散户资金净流入。技术指标显示，股价处于空头行情，MACD柱状图为负，KDJ指标偏低，布林带压力 位在2.79元附近，支撑位在2.47元，短期表现弱于大盘和行业指数。 财报分析 2025年度业绩预告显示，公司亏损同比收窄(2024年亏损1.1亿元) ...

经济观察网贝因美（002570）(002570.SZ)近期有多项事件值得关注，主要涉及控股股东预重整进展及 公司经营状况。根据最新公告和报道，以下事件需保持留意： 近期事件 控股股东预重整及投资人招募：贝因美控股股东浙江小贝大美控股有限公司的预重整方案已于2026年1 月30日获债权人会议表决通过，其管理人正公开招募意向投资人，意向方需在2026年3月4日17:00前提 交材料，并缴纳8000万元保证金。此次招募可能导致公司控制权发生变动，但公司强调与控股股东在业 务、人员等方面独立，生产经营正常未受影响。预重整程序自2025年7月获法院裁定受理，目前正处于 关键阶段。 业绩经营情况 近期财务表现：2025年前三季度，贝因美实现营业收入20.33亿元，同比下降2.6%；归母净利润1.06亿 元，同比增长48.1%；但经营活动现金流净额同比下降68.7%至1.03亿元，显示现金流压力。公司同期扣 非净利润同比增长76.2%，盈利能力有所提升。 公司状况 潜在风险事项：公司于2025年1月公告拟使用资产抵押申请贷款，抵押资产净值约9.87亿元；同时存在 未决诉讼，包括2025年12月起诉要求解除专利许可协议并追回 ...

经济观察网近7天(2026年02月06日至02月13日)，壹石通股价呈现震荡走势。根据内部数据库，02月13 日最新收盘价为29.50元，当日跌1.40%，成交额6636.00万元，换手率1.11%。区间内股价最高为02月09 日的31.02元，最低为02月12日的29.35元，区间涨跌幅为-1.21%，振幅5.59%。资金面上，02月13日主力 资金净流出442.79万元，连续多日呈现净流出态势；融资余额截至02月12日为3.30亿元，处于近期高 位。股价波动主要受新能源车及电池板块整体情绪影响，根据搜狐报道，公司勃姆石产品在钠离子电 池、半固态电池等领域的应用前景受到市场关注。 近期事件 近期公司融资活动活跃，02月12日融资买入额为725.02万元，融资余额维持在3.30亿元水平，占流通市 值比例较高。此外，根据同花顺（300033）数据，公司于02月03日披露的2025年业绩预告显示，预计年 度营收同比增长22.89%-26.86%，但净利润出现亏损，主要因研发投入及费用增加。该预告虽发布稍 早，但余波可能对近期股价形成压力。 以上内容基于公开资料整理，不构成投资建议。 ...

公司重整计划已于2025年12月执行完毕，形成约680亿元至700亿元的重整收益，计入非经常性损益。同 时，新任董事长郭伟及专家顾问团队(如马蔚华、冯仑等)已上任，重点推动资产盘活和业务转型。后续 关注点包括新战略(如投资管理、不动产运营)的落地效果。 公司基本面 尽管净利润扭亏，但2025年扣非净利润预计亏损290亿元至350亿元，反映主营业务仍承压。资金流向显 示，2026年1月主力资金净流出频繁，例如1月9日净流出1238.1万元，与大盘走势分化，表明市场对ST 个股持谨慎态度。长期表现需观察现金流改善及行业政策影响。 以上内容基于公开资料整理，不构成投资建议。 经济观察网根据最新公告和市场信息，ST金科(000656)有以下值得关注的事件： 业绩经营情况 公司于2026年1月30日发布业绩预告，预计2025年净利润为300亿元至350亿元，实现扭亏为盈；年末净 资产预计为50亿元至70亿元，由负转正。若经审计后符合条件，公司计划向深交所申请撤销退市风险警 示(即"摘帽")，最终结果取决于年报审计意见。2025年年度报告预计在近期披露，这将决定公司是否消 除退市风险。 重组进展 ...

Company Performance - The company expects a net loss of 40 million to 60 million yuan for 2025, but anticipates a profit of 450,000 to 675,000 yuan in net profit after excluding non-recurring gains and losses, indicating a narrowing of losses compared to 2024 [2] - The performance change is primarily attributed to the optimization of the ship operation structure, such as focusing on foreign trade routes, and cost control measures [2] Recent Events - The actual controller, Li Jianming, was released from residential surveillance in April 2024, but the related case has not yet been concluded. The company emphasizes that Li Jianming is not involved in daily operations, and the governance structure remains normal [3] Project Initiatives - In 2025, the company plans to implement a "scrap old and buy new" strategy, which includes dismantling old ships and applying for government subsidies (e.g., receiving a ship dismantling subsidy of 40.6728 million yuan in November 2025) and plans to purchase new ships with an investment of no more than 60 million USD [4] Financial and Technical Aspects - Since January 2026, there has been a net outflow of main funds multiple times (e.g., a net outflow of 5.921 million yuan on January 5 and 7.137 million yuan on January 9), putting pressure on the stock price. Market sentiment is influenced by the actual controller's case, industry cycles, and performance factors [5] Industry Policy and Environment - The dry bulk shipping industry is influenced by the global trade climate, with the coastal bulk freight index expected to remain stable and rise in 2025. Institutions forecast that the transportation industry may benefit from improved domestic demand in 2026, but attention should be paid to potential impacts of supply and demand changes on freight rates [6]

Core Viewpoint - The company, Olin Bio (688319.SH), is progressing towards a dual listing in Hong Kong, which could enhance its capital structure and international presence, while facing regulatory uncertainties regarding the approval process [1][2]. Stock Performance - As of February 13, 2026, Olin Bio's A-share price closed at 27.13 yuan, up 4.59%, with a trading volume of 255 million yuan and a turnover rate of 2.29% [1]. Strategic Advancement - The company aims to leverage the Hong Kong listing to accelerate its "bring in" (international patents and talent) and "go out" (global sales and technology transfer) strategies, focusing on differentiated areas such as superbug vaccines and adult vaccines [2]. - In November 2025, the company received a "satisfactory compliance" rating from the Philippines FDA, facilitating entry into the Southeast Asian market, and established a vaccine production partnership with Griffith University in Australia [2]. Project Development - The proceeds from the Hong Kong listing will be allocated to the clinical development of the rHPV (Helicobacter pylori) vaccine, expansion of the III phase clinical trials for the golden staph vaccine, and upgrades to production facilities [3]. - The restructured golden staph vaccine has completed enrollment of 6,000 cases for the III phase clinical trial, with complete data expected in the first half of 2026; the quadrivalent influenza virus split vaccine (MDCK cells) commenced its III phase clinical trial in October 2025 [3]. Future Development - The Hong Kong listing is anticipated to attract international investors, broadening financing channels, which is particularly beneficial for the long-term investment required in innovative vaccine research and development [4]. - A dual listing is expected to enhance the company's international visibility, promoting business development collaborations and expansion into overseas markets [5].

李志友严重违反党的政治纪律、组织纪律、廉洁纪律、生活纪律，构成严重职务违法并涉嫌受贿犯罪， 且在党的十八大后不收敛、不收手，特别是党的二十大后仍不知止，性质严重、影响恶劣，应予严肃处 理。依据《中国共产党纪律处分条例》《中华人民共和国监察法》《中华人民共和国公职人员政务处分 法》等有关规定，经内蒙古自治区纪委常委会会议研究并报内蒙古自治区党委批准，决定给予李志友开 除党籍处分；由内蒙古自治区监委给予其开除公职处分；将其涉嫌犯罪问题移送检察机关依法审查起 诉，所涉财物一并移送。 经济观察网 2月13日，中央纪委国家监委网站通报，据内蒙古自治区纪委监委消息：经内蒙古自治区党 委批准，内蒙古自治区纪委监委对内蒙古自治区民族事务委员会原党组成员、副主任李志友严重违纪违 法问题进行了立案审查调查。 经查，李志友丧失理想信念，背弃初心使命，违反政治纪律，对抗组织审查；违反中央八项规定精神， 违规收受礼品、礼金、消费卡，违规借用车辆，违规接受宴请和旅游安排；违反组织原则，在组织函询 时不如实说明问题，利用职务上的便利在职工录用、安置方面为他人谋取利益；违反廉洁纪律，通过民 间借贷谋取大额回报；"靠体育吃体育"，利用职务便利 ...

Core Viewpoint - The company is adjusting its related party transactions and advancing green technology research and carbon neutrality transformation. Group 1: Related Party Transactions - The company’s board approved an adjustment to the expected daily related party transactions for 2026, totaling 15.307 billion yuan, with the proposal submitted for shareholder review on February 11, 2026 [2]. Group 2: Project Advancement - The board has approved plans for technological upgrades, equipment renewal, technological innovation, and information technology projects aimed at enhancing production efficiency and facilitating low-carbon transformation, which may impact the company's medium to long-term competitiveness [3]. Group 3: Product Development Progress - The company is promoting the large-scale application of mercury-free PVC catalytic technology and is collaborating with research institutions to prepare for pilot testing of carbon dioxide hydrogenation to aviation kerosene technology, which could become a future business highlight [4]. Group 4: Industry Policy and Environment - The cancellation of the PVC export tax rebate policy in April 2026 is noted, with the company stating that its PVC export proportion is limited, and the overall impact is manageable, though industry supply and demand changes should be monitored [5]. Group 5: Future Development - The company is continuously exploring hydrogen coupling and green electricity substitution paths, with a 300MW photovoltaic project already in operation and ongoing research into energy storage technology to build an integrated "source-grid-load-storage" system [6].

经济观察网润禾材料（300727）近期值得关注的事件是其计划向不特定对象发行可转换公司债券。根据 公司2026年2月12日发布的募集资金使用可行性分析报告，本次发行募集资金总额不超过40,000万元， 拟用于高端有机硅新材料项目及补充流动资金，其中高端有机硅新材料项目计划建设期为36个月。公司 项目推进此外，公司液冷解决方案已在数据中心、储能等领域实现商业化落地，并与多家头部企业开展 合作，但相关进展属于当前业务状态而非未来事件。 以上内容基于公开资料整理，不构成投资建议。 ...

Core Viewpoint - The stock price of Shengde Xintai (300881) has experienced a pullback after reaching a new high, with significant net outflow of funds and a decline in net profit for the first three quarters [1][2][3]. Stock Performance - On February 13, 2026, Shengde Xintai's stock closed at 45.90 yuan, down 4.45%, after hitting a peak of 50.72 yuan on February 12, with a five-day cumulative increase of 9.36% [2]. Company Fundamentals - The company's net profit for the first three quarters was 152 million yuan, a year-on-year decrease of 21.38%, with a gross margin of 15.51%, down 3.81 percentage points [3]. Fund Flow Situation - On February 13, there was a net outflow of 15.64 million yuan from major funds, accounting for 10.45% of the trading volume, while retail investors showed a net inflow [4]. Industry Sector Situation - The special steel II industry index fell by 3.05%, and the overall steel sector declined by 2.46%, with Shengde Xintai's decline slightly exceeding the industry average [5]. Stock Price Situation - After breaking through the upper Bollinger Band at 47.04 yuan on February 12, the stock retreated to the middle band around 41.80 yuan on February 13, indicating a relief from short-term overbought pressure [6]. Financial Condition - The company has a high proportion of accounts receivable relative to net profit at 376.59%, along with cash flow pressures and potential uncertainties from raw material price fluctuations and new business development [7].